By David Wild
A small case series has confirmed that high-dose IV immune globulin (IVIG) can treat COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).
Although “use of high-dose IVIG to treat thrombosis is unusual, especially considering that thrombotic events have been well documented after IVIG administration in patients with immune thrombocytopenic purpura, in the case of … our three study patients with VITT, the inhibition of serum-induced platelet-activating